NASDAQ:EYEN • US30234E2037
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EYENOVIA INC (EYEN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-03-21 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-02-06 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2024-11-18 | Ladenburg Thalmann | Downgrade | Buy -> Neutral |
| 2024-11-18 | HC Wainwright & Co. | Downgrade | Buy -> Neutral |
| 2024-11-15 | Brookline Capital | Downgrade | Buy -> Hold |
| 2024-11-15 | William Blair | Downgrade | Outperform -> Market Perform |
| 2024-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-07-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-05-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-01 | William Blair | Initiate | Outperform |
| 2023-10-17 | Brookline Capital | Initiate | Buy |
| 2023-08-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-12 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-04-19 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-04-03 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-10-05 | HC Wainwright & Co. | Initiate | Buy |
| 2021-04-01 | HC Wainwright & Co. | Maintains | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | -100.00% | 3.8K | 57.3K 1,407.89% | 4.461M 7,685.34% | 18.53M 315.38% | 38.207M 106.19% | 42.867M 12.20% | 65.18M 52.05% | 86.393M 32.55% | 105.77M 22.43% | 114.61M 8.36% | |
| EBITDA YoY % growth | -26.6M -109.78% | -24.623M 7.43% | -36.402M -47.84% | -70.04M -92.41% | 36.8M 152.54% | 62.987M 71.16% | 90.214M 43.23% | 118.51M 31.37% | 147.91M 24.81% | N/A | N/A | |
| EBIT YoY % growth | -26.91M -108.60% | -25.406M 5.59% | -37.53M -47.72% | -33.477M 10.80% | -23.927M 28.53% | -9.476M 60.40% | -9.685M -2.21% | 6.514M 167.26% | 20.391M 213.03% | 32.097M 57.41% | 33.744M 5.13% | |
| Operating Margin | N/A | -668,589.47% | -65,497.91% | -750.45% | -129.13% | -24.80% | -22.59% | 9.99% | 23.60% | 30.35% | 29.44% | |
| EPS YoY % growth | -67.20 -64.71% | -53.60 20.24% | -50.93 4.98% | -33.86 33.51% | -26.52 21.69% | -13.06 50.77% | -4.29 67.11% | 1.43 133.25% | 6.13 329.29% | 9.91 61.73% | 10.26 3.50% |
All data in USD
| Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -7.34 56.29% | -6.53 25.82% | -6.53 5.80% | -8.16 -400.61% | -6.53 11.11% | -5.71 12.50% | -4.08 37.50% |
| Revenue Q2Q % growth | 612K 2,604.37% | 918K 45,800.00% | 1.224M 4,271.43% | 2.581M 17,106.67% | 3.907M 538.40% | 5.222M 468.85% | 8.017M 554.98% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -6.626M 43.31% | -6.076M 17.13% | -5.076M 38.43% | N/A | N/A | N/A | N/A |
All data in USD
8 analysts have analysed EYEN and the average price target is 163.2 USD. This implies a price increase of 931.61% is expected in the next year compared to the current price of 15.82.
EYENOVIA INC (EYEN) will report earnings on 2025-08-11, after the market close.
The consensus EPS estimate for the next earnings of EYENOVIA INC (EYEN) is -7.34 USD and the consensus revenue estimate is 612.00K USD.
The consensus rating for EYENOVIA INC (EYEN) is 47.5 / 100 . This indicates that analysts generally have a neutral outlook on the stock.